Stocks · Healthcare · Medical - Healthcare Information Services
Spok Holdings, Inc. SPOK
$10.89 +2.06% Close, Oct 2, 2026 · NASDAQ · Market cap $227.5M
High qualityInexpensive vs sectorLow risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Diluted EPS over the last four quarters was $0.58, down 30.1% year over year.
- Over the past year the stock returned -34.2%, behind the S&P 500 by 49.3 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 25%
- EPS growth (TTM, YoY)Bottom 33%
- FCF growth (TTM, YoY)Bottom 39%
- Revenue growth, 3-year CAGRBottom 26%
- Revenue growth accelerationBottom 36%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 18%
- Gross marginTop 21%
- Operating marginTop 19%
- Cash conversion (OCF / net income)Top 26%
- Accruals (lower is better)Top 40%
- Net debt / EBITDA (lower is better)Top 25%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 9%
- Free-cash-flow yieldTop 6%
- EBITDA / enterprise valueTop 8%
- Sales / enterprise valueTop 19%
- P/E vs own 5-year history (lower is better)Bottom 34%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 12%
- 6-month returnBottom 41%
- 1-year return vs S&P 500Bottom 19%
- Distance from 52-week highBottom 47%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 24%
- Consecutive EPS beatsBottom 49%
- Upside to consensus price targetBottom 39%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 3%
- Maximum drawdown, 3 yearsTop 18%
- Beta vs S&P 500 (lower is better)Top 19%
- Net debt / EBITDA (lower is better)Top 25%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -1.7% | -3.4% | ↓ |
| EPS growth (YoY) | -23.1% | -30.1% | ↓ |
| Gross margin | 69.8% | 88.1% | ↑ |
| Operating margin | 15.2% | 13.2% | ↓ |
| FCF margin | 18.0% | 18.7% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -3.4% | -1.7% | ↓ | Bottom 25% |
| EPS growth (TTM, YoY) | -30.1% | -23.1% | ↓ | Bottom 33% |
| Gross margin | 88.1% | 69.8% | ↑ | Top 21% |
| Operating margin | 13.2% | 15.2% | ↓ | Top 19% |
| Net margin | 9.0% | 12.1% | ↓ | — |
| Free-cash-flow margin | 18.7% | 18.0% | ↑ | — |
| Return on invested capital | 8.5% | — | Top 18% | |
| Revenue growth, 3-year CAGR | 1.3% | — | Bottom 26% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.34×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -8.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -5.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.47×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 12.01%
- Net buyback yield (TTM)
- 0.75%
- Shareholder yield
- 12.77%
- Share count change, 1 year
- +2.1%
- Share count change, 3-year CAGR
- +1.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -15.0%
- Average 2-day reaction, last 8
- -1.3%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $15.00
- Target vs current price
- +37.7%
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | +33.3% | +0.6% | +2.9% | -2.8% | — |
| Apr 29, 2026 | -50.0% | -3.7% | -5.2% | -7.8% | -7.7% |
| Feb 25, 2026 | -22.2% | -0.3% | -11.4% | -18.4% | -20.1% |
| Oct 29, 2025 | -21.1% | -3.7% | -16.1% | -20.2% | -17.6% |
| Jul 30, 2025 | +22.2% | -0.3% | +7.5% | +4.3% | -5.0% |
| Apr 30, 2025 | +38.9% | -0.6% | +14.5% | +12.2% | +21.2% |
| Feb 26, 2025 | -10.0% | -2.2% | -3.0% | -4.4% | -2.3% |
| Oct 30, 2024 | +0.0% | -0.7% | +5.9% | +8.8% | +9.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | $0.20 | $0.15 | +33.3% | $35.0M |
| Apr 29, 2026 | $0.09 | $0.18 | -50.0% | $33.2M |
| Feb 25, 2026 | $0.14 | $0.18 | -22.2% | $33.9M |
| Oct 29, 2025 | $0.15 | $0.19 | -21.1% | $33.9M |
| Jul 30, 2025 | $0.22 | $0.18 | +22.2% | $35.7M |
| Apr 30, 2025 | $0.25 | $0.18 | +38.9% | $36.3M |
| Feb 26, 2025 | $0.18 | $0.20 | -10.0% | $33.9M |
| Oct 30, 2024 | $0.18 | $0.18 | +0.0% | $34.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 18.8× | 17.8× | 60th | Top 9% |
| P/E (forward) | 16.5× | — | — | — |
| EV / EBITDA | 9.4× | — | — | Top 8% |
| EV / Sales | 1.59× | — | — | Top 19% |
| Free-cash-flow yield | 11.17% | — | — | Top 6% |
| Earnings yield | 5.33% | — | — | Top 9% |
P/E over the past five years
Range 7.7× – 22.9× since Dec 31, 2022. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -34.2%
- Earnings per share growth (TTM)
- -30.1%
- Change in P/E multiple
- -16.2%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 1
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +0.2%
- 200-day average slope (20 days)
- -2.1%
- Distance from 50-day average
- +1.5%
- Distance from 200-day average
- -5.3%
- RSI (14)
- 60.4
- Relative volume
- 0.91×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 22.8%
- Volatility vs own 5-year history
- 15th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.57
- Correlation with S&P 500
- 0.32
- Current drawdown from 1-year high
- -33.6%
- Maximum drawdown, 3 years
- -45.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 6, 2021 | Jul 1, 2022 | -50.9% | 374 days | 211 days (May 4, 2023) |
| Aug 13, 2025 | Jun 30, 2026 | -45.4% | 220 days | Not yet recovered |
| Feb 29, 2024 | Apr 28, 2025 | -23.1% | 290 days | 44 days (Jul 1, 2025) |
| Jun 22, 2023 | Jul 14, 2023 | -21.3% | 15 days | 10 days (Jul 28, 2023) |
| Nov 27, 2023 | Dec 15, 2023 | -20.0% | 14 days | 50 days (Feb 29, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $227.5M
- P/E (TTM)
- 18.8
- EPS, diluted (TTM)
- $0.58
- Revenue (TTM)
- $136.0M
- Dividend yield
- 11.48%
- 52-week range
- $9.95 – $16.63
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $142.2M | $134.5M | $139.0M | $137.7M | $139.7M |
| Gross profit | $69.9M | $75.3M | $81.9M | $109.2M | $110.1M |
| Operating income | -$12.1M | $7.6M | $21.8M | $19.0M | $19.7M |
| Net income | -$22.2M | $21.9M | $15.7M | $15.0M | $15.9M |
| EPS (diluted) | -$1.14 | $1.09 | $0.77 | $0.73 | $0.75 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.9M | $33.9M | $36.3M | $35.7M | $33.9M | $33.9M | $33.2M | $35.0M |
| Net income | $3.7M | $3.6M | $5.2M | $4.6M | $3.2M | $2.9M | $2.0M | $4.1M |
| EPS (diluted) | $0.18 | $0.18 | $0.25 | $0.22 | $0.15 | $0.14 | $0.09 | $0.20 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $8.0M | $6.5M | $26.2M | $28.9M | $28.9M |
| Capital expenditure | -$15.2M | -$3.8M | -$3.4M | -$3.2M | -$3.8M |
| Free cash flow | -$7.3M | $2.7M | $22.8M | $25.7M | $25.2M |
| Dividends paid | -$10.0M | -$25.0M | -$25.6M | -$26.4M | -$27.3M |
| Net share buybacks | -$1.9M | -$1.2M | -$1.2M | -$2.4M | -$2.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $16.6M
- Total assets
- $195.6M
- Total liabilities
- $55.7M
- Total debt
- $5.7M
- Net debt
- -$10.8M
- Shareholders’ equity
- $139.9M
As of Jun 30, 2026 (filed Jul 30, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 19, 2026 | $0.31 | Sep 9, 2026 |
| May 26, 2026 | $0.31 | Jun 24, 2026 |
| Mar 16, 2026 | $0.31 | Mar 31, 2026 |
| Nov 18, 2025 | $0.31 | Dec 9, 2025 |
| Aug 19, 2025 | $0.31 | Sep 9, 2025 |
| May 23, 2025 | $0.31 | Jun 24, 2025 |
| Mar 14, 2025 | $0.31 | Mar 31, 2025 |
| Nov 18, 2024 | $0.31 | Dec 9, 2024 |
Short interest
- Shares sold short
- 679,661
- Days to cover
- 5.75
- Change vs previous report
- +14.4%
FINRA short interest, settlement date Sep 15, 2026.